Publications & Abstracts

  • Do quantitative levels of antispike-IgG antibodies aid in predicting protection from SARS-CoV-2 infection? Results from a longitudinal study in a police cohort

    Sendi P, Widmer N, Branca M,
    Thierstein M, Büchi AE, Güntensperger D, Blum MR, Baldan R, Tinguely C, Heg D, Theel ES, Berbari
    E, Tande AJ, Endimiani A, Gowland P, Niederhauser C; PoliCOV-19 study J Med Virol. 2023
    Jul;95(7): e28904. https://doi.org/10.1002/jmv.28904

  • Neuropathies related to hepatitis E virus infection: A prospective, matched case–control study

    Ripellino R, Lascano AM, Scheidegger O, Schilg-Hafer L, Schreiner B, Tsouni P, Vicino A, Peyer AK,
    Humm A, Décard BF, Pianezzi E, Zezza G, Sparasci D, Hundsberger T, Dietmann A, Jung H, Kuntzer
    T, Wilder-Smith E, Martinetti-Lucchini G, Petrini O, Fontana S, Gowland P, Niederhauser C, Gobbi
    C. European Journal of Neurology. https://doi.org/10.1111/ene.16030

  • Versorgung von Patienten mit seltenen Blutgruppen (Prise en charge des patients présentants des groupes sanguins rares 

    Blanc C, Münger S, Lejon Crottet S, Still F. Labmag 8-9 / 2023; 213-218.
    Epidemiology of HEV Infection in Blood Donors in Southern Switzerland. Fontana S, Ripellino P,
    Niederhauser C, Widmer N, Gowland P, Petrini O, Aprile M, Merlani G and Bihl F. Microorganisms
    2023, 11, 2375. https://doi.org/10.3390/microorganisms11102375

  • Fetal RHD Screening in RH1 Negative Pregnant Women: Experience in Switzerland 

    Schimanski B, Kräuchi R , Stettler J , Lejon Crottet S , Niederhauser C , Banch Clausen F, Fontana S, Hodel
    M, Amylidi-Mohr S, Raio L, Abbal C and Henny C. Biomedicines 2023, 11, 2646.
    https://doi.org/10.3390/biomedicines11102646

  • "Don't add fuel to the fire"- Hyperhemolysis Syndrome in a pregnant woman with compound Sickle cell disease/ß0-thalassemia - Case report and review of the literature

    Rihsling A, Simeunovic H, Sanchez S, Henny C, Lejon Crottet S, Mansouri Teleghani B, Daskalakis
    M, Müller M, Raio L, Rovó A.. Acta Haematol. 2023 Oct 13. https://doi.org/10.1159/000533776 Epub
    ahead of print. PMID: 37839398.

  • In Vitro-Transfusional Model for Red-Blood-Cell Study: the Advantage of Lowering Hematocrit

    Längst E, Crettaz D, Delobel J, Renella R, Bardyn M, Turcatti G, Tissot J-D, and Prudent M
    Blood Transfus, 2023, 21, 277-288. https://doi.org/10.2450/2022.0086-22

  • The Effect of the Donor’s and Recipient’s Sex on Red Blood Cells Evaluated Using Transfusion
    Simulations

    Längst E, Crettaz D, Tissot J-D and Prudent M
    Cells, 2023, 12, 1454, 1-14. https://doi.org/10.3390/cells12111454

  • Phosphoproteomics and Morphology of Stored Human Red Blood Cells Treated by ProteinTyrosine-Phosphatases Inhibitor

    Bardyn M, Crettaz D, Rappaz B, Hamelin R, Armand F, Tissot J-D, Turcatti G, and Prudent M
    Blood Advances, 2023, On-line, https://doi.org/10.1182/bloodadvances.2023009964

  • Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors

    Schmidt J, Chiffelle J, Perez MAS, Magnin M, Bobisse S, Arnaud M, Genolet R, Cesbron J, Barras D,
    Navarro Rodrigo B, Benedetti F, Michel A, Queiroz L, Baumgaertner P, Guillaume P, Hebeisen M,
    Michielin O, Nguyen-Ngoc T, Huber F, Irving M, Tissot-Renaud S, Stevenson BJ, Rusakiewicz S, Dangaj Laniti D, Bassani-Sternberg M, Rufer N, Gfeller D, Kandalaft LE, Speiser DE, Zoete V, Coukos G, Harari A. Nat Commun. 2023 Jun 6;14(1):3188. https://www.nature.com/articles/s41467-023-38946-z

  • Overall avidity declines in TCR repertoires during latent CMV but not EBV infection

    Couturaud B, Doix B, Carretero-Iglesia L, Allard M, Pradervand S, Hebeisen M, Rufer N. Front Immunol. 2023 Nov 20;14:1293090. https://doi.org/10.3389/fimmu.2023.1293090 eCollection 2023. 

  • Understanding the parameters guiding the best practice for treating B-cell-depleted patients with COVID-19 convalescent plasma therapy

    Gachoud D, Bertelli C, Rufer N. Br J Haematol. 2023 Jan;200(2):e25-e27. https://doi.org/10.1111/bjh.18540

  • Epub 2022 Nov 10. Successful outcome of pregnancy post-allogeneic stem cell transplant despite severe RH1 alloimmunization: A case report 

    Gavillet M, Rufer N, Grandoni F, Rizzi M, Vulliemoz N, Baud D, Alberio L, Canellini G, Legardeur H. Br J Haematol. 2023 May;201(3):581-584. https://doi.org/10.1111/bjh.18741 Epub 2023 Mar 14. 

  • Inborn errors of type I interferon immunity in patients with symptomatic acute hepatitis E

    Saadat A, Gouttenoire J, Ripellino P, Semela D, Amar S, Frey BM, Fontana S, Mdawar-Bailly E, Moradpour D, Fellay J, Fraga M; HEV Human Genetics Collaborators: Badini G, Bergamin I, Bernsmeier C, Clerc O, Deibel A, Eichler K, Friedrich N, Sinnreich M F, Gagliarducci E, Gavillet M, Meylan D, Müllhaupt B, Niederhauser C, Rufer N, Schindler E, Zürcher M Hepatology. 2023 Dec 8. https://doi.org/10.1097/HEP.0000000000000701 Online ahead of print.

Abstracts

  • Neuropathies related to Hepatitis E virus infection in Switzerland: A prospective, matched case-control study 

    Ripellino P, Lascano AM, Schilg-Hafer L, Scheidegger O, Schreiner B, Tsouni P, Vicino A, Peyer A, Humm A, Décard BF, Pianezzi E, Zezza G, Sparasci D, Hundsberger T, Dietmann A, Jung H, Kuntzer T, Wilder-Smith E, Martinetti-Lucchini G, Fontana S, Niederhauser C, Gobbi C. 9th Congress of the European Academy of Neurology, 2023 Budapest

  • Immune events preceding neuralgic amyotrophy 

    Sparasci D, Schilg-Hafer L, Schreiner B, Scheidegger O, Peyer A , Lascano AM, Vicino A, Décard BF, Tsouni P, Humm A, Pianezzi E, Zezzi G, Hundsberger T, Dietmann A, Jung H, Kuntzer T, Wilder-Smith E, Martinetti-Lucchini G, Fontana S, Niederhauser C, Gobbi C, Ripellino P. Peripheral Nerve Society Annual Meeting, 2023 Copenhagen

  • Analysis of Routine Specificity Data of Roche Diagnostics Infectious Disease Screening Assays for HIV, HBV, HCV, HTLV, Syphilis and Chagas in 6 Blood Screening Centres 

    Pistorius C, Pietersen N, Cable R, Tinguely C, Niederhauser C, Majchrzak M, Arriaga G, Guillet M. ISBT 2023, 18–21 November, Cape Town

  • Identification of Three Novel ABO Blood Group Alleles 

    Lejon Crottet S, Kräuchi R, Niederhauser C, Rüfli T, Mihm B, Levrat E and Henny C, ISBT 2023 Göteborg

  • sCD38: A soluble protein for mitigation of therapeutic anti-CD38 in the indirect antiglobulin test

    Lejon Crottet S, Locher N, Caesar A, Feuerhahn S and Niederhauser C, Swisstransfusion 2023

  • Implementation of Erytra automated analyser for Blood Group Typing in a Blood Donor Setting: Experience and first results

    Tinguely C., Gfeller B., Still F., Lejon Crottet S., Niederhauser C ISBT 2023 Göteborg & Swisstransfusion 2023 als Poster

  • Prevalence of acute Hepatitis E virus infections in Swiss Blood Donations 2018-2020

    Niederhauser C, Gowland P, Widmer N, Amar El Dusouqui S, Mattle M, Gottschalk J, Frey BM. Abstract presented at 33rd Regional Congress of the ISBT, Gothenburg, Sweden, 2023

  • Anti-SARS-CoV-2 antibody development during the COVID-19 pandemic in Swiss blood donors

    Gowland P, Widmer N, Tinguely C, Fontana S, Pehlic V, Thierbach J, Waldvogel Abramowski S, Züger M, Niederhauser C. Abstract presented at 33rd Regional Congress of the ISBT, Gothenburg, Sweden, 2023 and Swisstransfusion Kongress 2023. Rorschach

  • Two novel alleles harboring a deletion in the KEL and RH blood group system 

    C Henny, R Kräuchi, C Niederhauser, M Gavillet, T Gleich-Nagel, S Lejon Crottet. Abstract presented at 33rd Regional Congress of the ISBT, Gothenburg, Sweden, 2023

  • Blood group genotyping in donors of Africant descent 

    Kräuchi R, Lejon Crottet S, Niederhauser C, Infanti L, T Rüfli T, Henny C Abstract presented at 33rd Regional Congress of the ISBT, Gothenburg, Sweden, 2023

  • Routine testing for RHD*01W.1, RHD*01W.2 and RHD*01.W3 subtype alleles is dispensable in Switzerland

    Schimanski B, Kräuchi R, Lejon Crottet S, Niederhauser C and Henny C Abstract presented at 33rd Regional Congress of the ISBT, Gothenburg, Sweden, 2023

  • Fetal RHD Screening in RH1 negative pregnant women: Experience in Switzerland 

    Kräuchi R, Schimanski B, Lejon Crottet S, Niederhauser C, Hodel M, Amylidi S, Raio L and Henny C Abstract presented at 33rd Regional Congress of the ISBT, Gothenburg, Sweden, 2023

  • Dépistage en routine du VHE RNA depuis octobre 2018 en Suisse

    Niederhauser C, Gowland P, Widmer N, Amar El Dussouqui S, Mattle M, Gottschalk J, Frey BM. Transfusion Clinique et Biologique Novembre 2023 SFTS, L15-3, page 516.

  • Validation data of a hypoxic red blood cell processing and storage system

    Martin A, Crettaz D, Bergeron P. Walicka-Philippo I, Prudent M
    Poster, ISBT 2023, Gothenburg, Sweden, June 2023
    Vox Sanguinis, 2023, 118(Suppl 1), P148. https://doi.org/10.1111/vox.13433

  • Discrimination of agonists-stimulated platelet phenotypes depending on pathogen inactivation and storage temperature in a blood bank

    Muret C, Crettaz D, Alberio L, Prudent M
    Poster International Society of Thrombosis and Hemostasis (ISTH) 2023, Montreal, Canada, June 2023

  • Optimization of the pooling time during the preparation of platelet concentrates in octopus configuration with a new sterile multiple connection device

    Martin A, Muhtari S, Feldmann J, Zehnder M, Benzoni M, Prudent M
    Poster, DGTI 2023, Berlin, Germany, Sept. 2023

  • Evaluation d’un nouvel appareil à connexions stériles multiples pour le mélange des Buffy-Coats en configuration Octopus

    Martin A, Muhtari S, Feldmann J, Zehnder M, Benzoni M, Prudent M
    Poster, SFTS 2023, Toulouse, France, Nov. 2023

  • Analyses phosphoprotéomiques et fonctionnelles des plaquettes traitées par inactivation des pathogènes et conservées à froid ou à température ambiante

    Muret C, Crettaz D, Alberio L, Prudent M
    Oral presentation, SFTS 2023, Toulouse, France, Nov. 2023

  • Modulation du phosphoprotéome et morphologie des globules rouges stockés

    Bardyn M, Crettaz D, Rappaz B, Hamelin R, Armand F, Tissot J-D, Turcatti G, Prudent M
    Oral presentation, SFTS 2023, Toulouse, France, Nov. 2023

  • Specific TCR/CDR mutations positively or negatively modulate the functional efficacy of NY-ESO-1-redirected CD8 T cells in a mutually exclusive manner

    Doix B, Tardivon D, Duong MM, Vincent K, Zoete V, Hebeisen M and Rufer N
    4th International

 

  • Transfusion-Transmitted Malaria and Mitigation Strategies in Nonendemic Regions 

    Niederhauser N, Galel Susan A. Transfus Med Hemother 2022;49:205-216. https://doi.org/10.1159/000525414

  • Prevalence of anti-tick-borne encephalitis virus (TBEV) antibodies in Swiss blood donors in 2014-2015

    Ackermann-Gäumann R, Eyer C, Vock M, Gowland P, Tinguely C, Leib SL, Bori M, Buser A, Fontana S, Thierbach J, Weingand T, Niederhauser C. Blood Transfus 2022; https://doi.org/10.2450/2022.0099-22

  • Antibody response and intra-host viral evolution after plasma therapy in COVID-19 patients pre-exposed or not to B-cell depleting agents 

    Gachoud D, Pillonel T, Tsilimidos G, Battolla D, Dumas D, Opota O, Fontana S, Vollenweider P, Manuel O, Greub G, Bertelli C, Rufer N. British J Hematol. 2022; 13:10.111/bjh.18450. https://doi.org/10.1111/bjh.18450

  • Understanding the parameters guiding the best practice for treating B-cell-depleted patients with COVID-19 convalescent plasma therapy

    Gachoud D, Bertelli C, Rufer N. British J Hematol. 2022, in press. https://doi.org/10.1111/bjh.18540

  • Accès au lait de donneuses en Suisse et création de la première banque de lait maternel romande au CHUV : enjeux et perspectives

    Fischer-Fumeaux C, Barin J, Prudent M, C Richard, Martin A, Henriot I, Legardeur H, Kaech C, May H, Vuignier J, Tolsa J-F Rev Med Suisse, 2022, 18, 59-63. https://doi.org/10.53738/revmed.2022.18.764-65.59

  • Antioxidants in single methylene-blue-treated plasma units cannot be used to predict pathogen inactivation treatment success

    Lotens A, Prudent M and A. Rapaille Vox Sanguinis, 2022, 117, 937-942. https://doi.org/10.1111/vox.13273

  • Effect of mercury on membrane proteins, anionic transport and cell morphology in human erythrocytes 

    Notariale R, Längst E, Perrone P, Crettaz D, Prudent M and Manna C Cell Physiol Biochem, 2022, 56, 500-513. https://doi.org/10.33594/000000572

  • A Dynamic Constraint-based Modelling (DCBM) Approach with Alternative Metabolic Objective Functions Predicts The impact of Oxidative Stress 

    Yasemi M, Prudent M, Jolicoeur M. IFAC PapersOnLine, 2022, 55-20, 385-390. https://doi.org/10.1016/j.ifacol.2022.09.125

  • Two novel platelet biotinylation methods and their impact on stored platelet concentrates in a blood bank environment 

    Muret C, Crettaz D, Martin A, Aliotta A, Bertaggia Calderara D, Alberio L and Prudent M Transfusion, 2022, 62, 2324-2333. https://doi.org/10.1111/trf.17129

  • In Vitro-Transfusional Model for Red-Blood-Cell Study: the Advantage of Lowering Hematocrit 

    Längst E, Crettaz D, Delobel J, Renella R, Bardyn M, Turcatti G, Tissot J-D, and Prudent M Blood Transfus, 2022, Early view. https://doi.org/10.2450/2022.0086-22

  • Evolution of Blood Safety in Switzerland over the Last 25 years for HIV, HCV, HBV and Treponema pallidum

    Niederhauser C, Tinguely C, Stolz M, Vock M, Amar El Dusouqui S, Gowland P.
    Viruses 2022, 14(12), 2611; https://doi.org/10.3390/v14122611 - 23 Nov 2023

  • The Disease Burden of Delta and Omicron Variants of SARS-CoV-2 in a Predominantly Vaccinated and Healthy Cohort

    Parham S Branca M, Büchi A, Widmer N, Tande A, Gowland P, and PoliVOV-19 study team. The Disease Burden of Delta and Omicron Variants of SARS-CoV-2 in a Predominantly Vaccinated and Healthy Cohort; Clinical Clin Microbiol Infect. 2022 Sep 3:S1198-743X(22)00456-6. https://doi.org/10.1016/j.cmi.2022.08.019. Online ahead of print.

  • Serosurveillance after a COVID‐19 vaccine campaign in a Swiss police cohort

    Sendi P, Thierstein M, Widmer N, Babongo Bosombo F, Büchi AE, Güntensperger D, Blum MR, Baldan R, Tinguely C, Gahl B, Heg D, Theel ES, Berbari E, Endimiani A, Gowland P, Niederhauser C PoliCOV‐19 study. Immun Inflam and Disease, May 4th 2022, https://doi.org/10.1002/iid3.640

  • Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients

    Purde MT, Niederer R, Wagner NB, Diem S, Berner F, Ali OH, Hillmann D, Bergamin I, Joerger M, Risch M, Niederhauser C, LenzTL, Früh M, Risch L, Semela D, Flatz L. J Cancer Res Clin Oncol. 2022 Mar;148(3):647-656. https://doi.org/10.1007/s00432-021-03870-6 Epub 2021 Dec 7.